Patients Have Higher Health Care Use After COVID-19 Infection
Alopecia, bronchitis, pulmonary embolism or deep vein thrombosis, and dyspnea are the most common conditions tied to higher use
Alopecia, bronchitis, pulmonary embolism or deep vein thrombosis, and dyspnea are the most common conditions tied to higher use
Following an episode of acute kidney injury, patients who transition to chronic kidney disease have a significant 1.5-fold increased long-term risk for infection, a study found.
Increases in resistant infections from 2019 to 2020 seen for carbapenem-resistant Acinetobacter, antifungal-resistant Candida auris
Coinfection increased mortality risk among kidney transplant recipients with COVID-19, a study found.
Tissue inhibitor of metalloproteinases 2 (TIMP-2) and insulinlike growth factor binding protein 7 (IGFBP7) could be used for AKI staging.
Data from the TESTING trial can inform patient-physician discussions.
A study of patients receiving maintenance hemodialysis revealed that those who contracted COVID-19 were more likely to die in the 90-day post-COVID-19 period than those who did not have COVID-19.
Surgeons transplanted kidneys from genetically modified pigs into brain-dead recipients.
Despite a decreasing overall radical cystectomy complication rate, the surgery still is associated with significant morbidity, according to investigators.
Adverse effects of induction therapies for lupus nephritis may limit their use.